Pirarubicin Hydrochloride

盐酸吡柔比星

Report date: 2023/10/19 17:57:26
NME

Base Information

Drug NamePirarubicin Hydrochloride
Drug Alias NameTHP-ADM比柔吡星Tetrahydropyranyl doxorubicin吡喃阿霉素THP-doxorubicin +[19] 
ClassificationSmall molecules > Heterocyclic drugs > AntibioticsSmall molecules > Heterocyclic drugs > Antibiotics > Anthracycline antibiotics
Mechanisms of ActionTopoisomerase II inhibitorsRNA synthesis inhibitors
TargetsTopoisomerase II
Therapy Area/IndicationsUrinary Bladder NeoplasmsUreteral NeoplasmsUterine Cervical Neoplasms +[11] 
Global Approved IndicationsBreast Neoplasms
Approved Indications in ChinaBreast Neoplasms
Original Approved Country/TerritoryJapan
Original Approved DateN/A
Country/TerritoryMainland ChinaJapan
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesShenzhen Main Luck Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesShenzhen Main Luck Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsUrinary Bladder NeoplasmsUreteral NeoplasmsUterine Cervical Neoplasms +[11] 
Inactive IndicationsN/A

Other Information

ATC CodeL01DB08
Related LinksWikipediaDrugBankKEGG